These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 15224345

  • 1. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
    Fujimoto E, Satoh H, Negishi E, Ueno K, Nagashima Y, Hagiwara K, Yamasaki H, Yano T.
    Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
    [Abstract] [Full Text] [Related]

  • 2. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H, Senba H, Virgona N, Fukumoto K, Ishida T, Hagiwara H, Negishi E, Ueno K, Yamasaki H, Yano T.
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [Abstract] [Full Text] [Related]

  • 3. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E, Sato H, Nagashima Y, Negishi E, Shirai S, Fukumoto K, Hagiwara H, Hagiwara K, Ueno K, Yano T.
    Life Sci; 2005 Apr 22; 76(23):2711-20. PubMed ID: 15792837
    [Abstract] [Full Text] [Related]

  • 4. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E, Sato H, Shirai S, Nagashima Y, Fukumoto K, Hagiwara H, Negishi E, Ueno K, Omori Y, Yamasaki H, Hagiwara K, Yano T.
    Oncogene; 2005 May 19; 24(22):3684-90. PubMed ID: 15782139
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
    Fujimoto E, Sato H, Shirai S, Nagashima Y, Virgona N, Hagiwara K, Yamasaki H, Negishi E, Ueno K, Yano T.
    Oncol Rep; 2006 May 19; 15(5):1359-65. PubMed ID: 16596211
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H, Hagiwara H, Senba H, Fukumoto K, Nagashima Y, Yamasaki H, Ueno K, Yano T.
    Mol Carcinog; 2008 Jun 19; 47(6):403-9. PubMed ID: 18058801
    [Abstract] [Full Text] [Related]

  • 7. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
    Takano Y, Iwata H, Yano Y, Miyazawa M, Virgona N, Sato H, Ueno K, Yano T.
    Biochem Pharmacol; 2010 Aug 15; 80(4):463-70. PubMed ID: 20510207
    [Abstract] [Full Text] [Related]

  • 9. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
    Hada S, Sato H, Virgona N, Hagiwara H, Saito T, Suzuki K, Asano R, Yano T.
    Oncol Rep; 2006 Nov 15; 16(5):1149-54. PubMed ID: 17016607
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [Abstract] [Full Text] [Related]

  • 11. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells.
    Sato A, Sekine M, Kobayashi M, Virgona N, Ota M, Yano T.
    Chemotherapy; 2013 Jun 01; 59(3):192-9. PubMed ID: 24335094
    [Abstract] [Full Text] [Related]

  • 12. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
    Sato H, Fukumoto K, Hada S, Hagiwara H, Fujimoto E, Negishi E, Ueno K, Yano T.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):449-57. PubMed ID: 17569045
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I, Jiang H, Ewerdwalbesloh N, Doehn C, Krüger S, Sczakiel G, Jocham D.
    BJU Int; 2005 Feb 01; 95(3):416-20. PubMed ID: 15679806
    [Abstract] [Full Text] [Related]

  • 14. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
    Yano T, Ito F, Kobayashi K, Yonezawa Y, Suzuki K, Asano R, Hagiwara K, Nakazawa H, Toma H, Yamasaki H.
    Cancer Lett; 2004 May 28; 208(2):137-42. PubMed ID: 15142671
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
    Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M.
    J Urol; 2008 Aug 28; 180(2):729-36. PubMed ID: 18555493
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene.
    Fujimoto E, Yano T, Sato H, Hagiwara K, Yamasaki H, Shirai S, Fukumoto K, Hagiwara H, Negishi E, Ueno K.
    J Pharmacol Sci; 2005 Feb 28; 97(2):294-8. PubMed ID: 15699574
    [Abstract] [Full Text] [Related]

  • 17. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
    Hagiwara H, Sato H, Ohde Y, Takano Y, Seki T, Ariga T, Hokaiwado N, Asamoto M, Shirai T, Nagashima Y, Yano T.
    Br J Pharmacol; 2008 Apr 28; 153(7):1373-81. PubMed ID: 18264126
    [Abstract] [Full Text] [Related]

  • 18. Connexin-32 acts as a downregulator of growth of thyroid gland.
    Prost G, Bernier-Valentin F, Munari-Silem Y, Selmi-Ruby S, Rousset B.
    Am J Physiol Endocrinol Metab; 2008 Feb 28; 294(2):E291-9. PubMed ID: 18042666
    [Abstract] [Full Text] [Related]

  • 19. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T, Huang WC, Seo S, Zhau HE, Mimata H, Chung LW.
    J Urol; 2007 Jul 28; 178(1):292-300. PubMed ID: 17499801
    [Abstract] [Full Text] [Related]

  • 20. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Oncol Rep; 2005 Jul 28; 14(1):73-9. PubMed ID: 15944770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.